Last updated: July 28, 2022
Sponsor: Galderma R&D
Overall Status: Completed
Phase
3
Condition
Skin Aging
Treatment
N/AClinical Study ID
NCT00647556
US10067
Ages > 40 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Male or Female aged 40 years of age and older with Fitzpatrick skin types I throughIII
- Clinically moderate to severe photodamage
Exclusion
Exclusion Criteria:
- Subjects with history of laser resurfacing, dermabrasion, medium or deep chemical peelof the face
- Subjects with diagnosis of skin cancer within 3 months of study entry
- Subjects who have had superficial chemical peels, exfoliation or microdermabrasion ofthe face within 3 months of study entry
- Subjects who have had botulinum toxin for facial rejuvenation within 6 months of studyentry and are unwilling to refrain from botulinum toxin treatments during the study
Study Design
Total Participants: 30
Study Start date:
April 01, 2008
Estimated Completion Date:
January 31, 2010
Study Description
Connect with a study center
University of Michigan Department of Dermatology
Ann Arbor, Michigan 48109
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.